Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review

  • ID: 4284761
  • SWOT Analysis
  • 49 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Cipla Ltd
  • Intas Pharmaceuticals Ltd
  • Lupin Ltd
  • Ranbaxy Laboratories Inc.
  • MORE
Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

Jul 04, 2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka
May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018
Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board
Mar 27, 2018: Piramal Pharma Solutions Wins in Six Categories at the ‘CMO Leadership Awards 2018’
Jan 30, 2018: Piramal Enterprises Q3 net profit up 21% at Rs 4.90 billion

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Cipla Ltd
  • Intas Pharmaceuticals Ltd
  • Lupin Ltd
  • Ranbaxy Laboratories Inc.
  • MORE
Section 1 - About the Company
  • Piramal Enterprises Ltd - Key Facts
  • Piramal Enterprises Ltd - Key Employees
  • Piramal Enterprises Ltd - Key Employee Biographies
  • Piramal Enterprises Ltd - Major Products and Services
  • Piramal Enterprises Ltd - History
  • Piramal Enterprises Ltd - Company Statement
  • Piramal Enterprises Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Piramal Enterprises Ltd - Business Description
  • Business Segment: Financial services
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Healthcare Insights & Analytics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Outside India
  • Performance
  • Business Segment: Pharmaceuticals Manufacturing and Services
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Eliminations
  • Performance
  • Geographical Segment: India
  • Performance
  • R&D Overview
  • Piramal Enterprises Ltd - Corporate Strategy
  • Piramal Enterprises Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Piramal Enterprises Ltd - Strengths
  • Piramal Enterprises Ltd - Weaknesses
  • Piramal Enterprises Ltd - Opportunities
  • Piramal Enterprises Ltd - Threats
  • Piramal Enterprises Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Piramal Enterprises Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 04, 2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka
  • May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018
  • Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board
  • Mar 27, 2018: Piramal Pharma Solutions Wins in Six Categories at the ‘CMO Leadership Awards 2018’
  • Mar 22, 2017: Piramal Pharma Solutions Augments Integrated Capabilities by Expanding Sterile Manufacturing Capabilities in Lexington, KY
  • Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
  • Mar 15, 2017: Piramal Swasthya and National Health Mission (NHM), Govt. of Assam partnership: Citizen Health Consultations and Services for Vulnerable and Remote Communities Reach Nearly 2 crore Mark
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Piramal Enterprises Ltd, Key Facts
  • Piramal Enterprises Ltd, Key Employees
  • Piramal Enterprises Ltd, Key Employee Biographies
  • Piramal Enterprises Ltd, Major Products and Services
  • Piramal Enterprises Ltd, History
  • Piramal Enterprises Ltd, Other Locations
  • Piramal Enterprises Ltd, Subsidiaries
  • Piramal Enterprises Ltd, Key Competitors
  • Piramal Enterprises Ltd, Ratios based on current share price
  • Piramal Enterprises Ltd, Annual Ratios
  • Piramal Enterprises Ltd, Annual Ratios
  • Piramal Enterprises Ltd, Annual Ratios
  • Piramal Enterprises Ltd, Interim Ratios
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Piramal Enterprises Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Piramal Enterprises Ltd, Performance Chart (2014 - 2018)
  • Piramal Enterprises Ltd, Ratio Charts
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Biocon Ltd
  • Sun Pharmaceutical Industries Ltd
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Cadila Healthcare Ltd
  • Intas Pharmaceuticals Ltd
  • Cipla Ltd
  • Ranbaxy Laboratories Inc.
  • Emcure Pharmaceuticals Ltd
  • Lupin Ltd
  • Dr. Reddy's Laboratories Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll